Frontiers in Endocrinology (Mar 2022)

Insulin Allergy to Detemir Followed by Rapid Onset of Diabetic Ketoacidosis: A Case Report and Literature Review

  • Chong Boon Teo,
  • Pek Yan Tan,
  • Shan Xian Lee,
  • Joan Khoo,
  • Jun Guan Tan,
  • Su Fen Ang,
  • Sze Hwa Tan,
  • Tunn Lin Tay,
  • Eberta Tan,
  • Su Chi Lim,
  • Su Chi Lim,
  • Bernhard O. Boehm,
  • Bernhard O. Boehm,
  • Bernhard O. Boehm,
  • Wann Jia Loh

DOI
https://doi.org/10.3389/fendo.2022.844040
Journal volume & issue
Vol. 13

Abstract

Read online

The management of diabetes mellitus in an insulin-dependent patient is challenging in the setting of concomitant antibody-mediated-insulin hypersensitivity. We report a case of a 62-year-old woman with pre-existing type 2 diabetes mellitus of 10 years duration who developed type 3 hypersensitivity reaction to insulin analogue detemir, and subsequently, severe diabetic ketoacidosis (DKA). She was C-peptide negative and was diagnosed with insulin-dependent diabetes. Despite increasing dose adjustments, insulin-meal matching, and compliance with insulin, she experienced episodes of unexpected hyperglycaemia and hypoglycaemia. The development of rash after detemir initiation and rapid progression to DKA suggests an aberrant immune response leading to the insulin allergy and antibody-induced interference with insulin analogues. Glycaemic control in the patient initially improved after being started on subcutaneous insulin infusion pump with reduced insulin requirements. However, after a year on pump therapy, localised insulin hypersensitivity reactions started, and glycaemic control gradually deteriorated.

Keywords